1. Pharmacoeconomics of Coxib Therapy
Scott B Cantor, PhD 
Journal of Pain and Symptom Management 
Volume 24, Issue 1, Pages S28-S37 (July 2002)
DOI: /S (02)

2. Fig. 1 Schematic of the health policy space.
Journal of Pain and Symptom Management  , S28-S37DOI: ( /S (02) )

3. Fig. 2
The COMET decision tree used to evaluate celecoxib versus five other arthritis treatment strategies: NSAID alone, NSAID plus proton pump inhibitor (PPI), NSAID plus H2-receptor antagonist (H2RA), NSAID plus misoprostol, and diclofenac plus misoprostol.7 (Adapted from Chancellor, et al., with permission.)
Journal of Pain and Symptom Management  , S28-S37DOI: ( /S (02) )

4. Fig. 3
Decision-tree model for the rofecoxib analysis with base-case probabilities.6 (From Pellissier et al., with permission).
Journal of Pain and Symptom Management  , S28-S37DOI: ( /S (02) )